Merck Gesellschaft mbH, Austria
5
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.0%
1 terminated/withdrawn out of 5 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Lipid Profile and Diabetes Mellitus in People With HIV
Role: collaborator
A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis
Role: collaborator
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria
Role: collaborator
Bisoprolol in Hypertension: Effect on Concomitant Elevated Heart Rate
Role: collaborator
Preoperative Chemoradiation With Capecitabine and Cetuximab
Role: collaborator
All 5 trials loaded